New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 7, 2012
07:24 EDTBRLIBio-Reference Labs downgraded to Underperform from Neutral at Macquarie
Macquarie downgraded Bio-Reference Labs following the Q4 miss citing margin pressure and reimbursement cuts. Price target is $25.
News For BRLI From The Last 14 Days
Check below for free stories on BRLI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
10:49 EDTBRLIBio-Reference downgraded to Underperform from Buy at BofA/Merrill (pre-open)
Subscribe for More Information
August 27, 2014
08:38 EDTBRLIBio-Reference Labs sees Q4 EPS 62c-64c, consensus 63c
Subscribe for More Information
08:34 EDTBRLIBio-Reference Labs reports Q3 EPS 55c, consensus 53c
Reports Q3 revenue $222.05M, consensus $210.44M. Reports Q3 EPS after taxes 53c. The number of patients served increased 16% to 2,511 in Q3 up from the 3Q13 total of 2,161. Esoteric business for the company was 68% of revenues for Q3 compared to 64% in 3Q13. Days Sales Outstanding, or DSO, was 105 days in Q3 compared to 3Q13 when the DSO was 95 days.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use